BiomEdge Showcases Shotgun Sequencing Microbiome Tests at The Pharmacy Show 2025
)
Birmingham, UK — 12-13 October 2025 — BiomEdge Ltd, a leader in advanced microbiome diagnostics, is proud to announce its participation in The Pharmacy Show 2025, the UK’s largest event for pharmacy professionals. The company will present its cutting-edge microbiome testing solutions, designed to transform the way health professionals approach prevention, diagnosis, and personalised care.
At the heart of BiomEdge’s innovation is its use of Shotgun Metagenomic Sequencing — a powerful, comprehensive technology that goes far beyond conventional 16S rRNA testing. This advanced approach enables BiomEdge to map the entire microbiome with unparalleled precision, providing insights into the root causes of disease rather than merely addressing symptoms.
“Our mission is to enable health professionals to deliver truly personalised care,” said Attila Suhajda, Managing Director of BiomEdge Ltd. “By understanding the microbiome at a deeper level, we can identify imbalances and pathogens that drive disease — and help patients take proactive steps to restore health, not just manage it.”
BiomEdge’s microbiome tests are designed for clinicians, pharmacists, nutritionists, and integrative practitioners seeking science-based tools to enhance patient outcomes. By combining detailed microbial profiling with actionable reports, the company’s solutions empower healthcare professionals to make data-driven decisions in areas such as gut health, immune function, metabolism, and chronic disease management.
Visitors to Stand 39 at The Pharmacy Show will have the opportunity to:
- Discover BiomEdge’s microbiome tests powered by Shotgun Sequencing technology
- Learn how advanced microbiome diagnostics can support prevention, precision medicine, and holistic patient care
- Explore partnership opportunities and affiliate programmes for healthcare professionals
As interest in the microbiome continues to grow, BiomEdge stands at the forefront of innovation, bridging the gap between science and practical healthcare solutions. Its advanced diagnostics offer a new paradigm — one that targets the cause of disease and supports long-term wellness through evidence-based insights.
About BiomEdge Ltd
BiomEdge Ltd is a UK-based provider of advanced microbiome testing solutions for health professionals and individuals. Using state-of-the-art Shotgun Sequencing technology, BiomEdge delivers comprehensive microbiome insights that support prevention, diagnosis, and personalised treatment strategies. The company is committed to advancing the science of the microbiome and driving innovation in healthcare through collaboration and technology.
Media Contact:
Attila Suhajda
Managing Director, BiomEdge Ltd
📧 info@biomedge.co.uk
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.png/fit-in/500x500/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
)
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
)
)
)
){kind=logo}
